| Dr Robert Lynn, MD, PA | |
|
134 Baltimore St, Cumberland, MD 21502-2302 | |
| (301) 777-0620 | |
| (301) 777-2906 |
| Full Name | Dr Robert Lynn |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 134 Baltimore St, Cumberland, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891792461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | D0055564 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Lynn, MD, PA 134 Baltimore St, Cumberland, MD 21502-2302 Ph: (301) 777-0620 | Dr Robert Lynn, MD, PA 134 Baltimore St, Cumberland, MD 21502-2302 Ph: (301) 777-0620 |
News Archive
Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
The National Council on Aging has formed a multi-year strategic alliance with DPS Health, a leader in clinically-proven online and mobile behavior change interventions for the emergent-risk population.
The Supreme Court was asked on Wednesday to hear a challenge to the health care overhaul law, raising the possibility that the justices could rule on the matter by next summer, just months before the presidential election.
KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.
Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).
› Verified 5 days ago
Saiqa Choudhry, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 302, Cumberland, MD 21502 Phone: 301-777-1930 Fax: 301-777-8470 | |
Dr. Nirmalam Nagulendran, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 301-777-5627 Fax: 301-777-5630 | |
Dr. Jeremy Alan Herschler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd Se, Cumberland, MD 21501 Phone: 301-759-5280 | |
Edward Michael Ehlers, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 Seton Dr, Cumberland, MD 21502 Phone: 301-723-5030 Fax: 301-723-6485 | |
Samuel Navaratnam Nava, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 81 Baltimore St, Suite 216, Cumberland, MD 21502 Phone: 301-777-9330 | |
Stephen Schellhase, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 915 Bishop Walsh Rd, Cumberland, MD 21502 Phone: 301-724-7277 Fax: 301-724-7022 | |
Steven F Kendell, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd Ste 380, Cumberland, MD 21502 Phone: 240-964-8585 Fax: 240-964-8586 |